The University Of Birmingham

Haematological Malignancies

Clinical research includes acute myeloid leukaemia, high-risk myelodysplastic syndrome, isolated myeloid sarcoma, polycythaemia vera, and mature B-cell non-Hodgkin lymphoma, with interest in relapsed, refractory, and newly diagnosed disease.

  • Acute myeloid leukaemia
  • Myelodysplastic syndrome
  • Polycythaemia vera
  • B-cell non-Hodgkin lymphoma

Work in this area spans systemic treatment strategies, targeted therapy, and stem cell transplant-related care.

Paediatric Solid Tumours

The sponsor is active in neuroblastoma, medulloblastoma, rhabdomyosarcoma, Ewing sarcoma, and soft tissue sarcoma, with studies addressing both frontline and relapsed disease.

  • Neuroblastoma
  • Medulloblastoma
  • Ewing sarcoma
  • Rhabdomyosarcoma
  • Non-rhabdomyosarcomatous soft tissue sarcoma

Research interest also covers metastatic disease, high-risk disease, and treatment planning for difficult-to-resect tumours.

Paediatric Liver and Germ Cell Tumours

Trials include hepatoblastoma and hepatocellular carcinoma, alongside malignant germ cell tumours and other hepatic malignancies requiring coordinated oncological and surgical management.

  • Hepatoblastoma
  • Hepatocellular carcinoma
  • Malignant germ cell tumour

These studies reflect interest in paediatric hepatology, liver cancer, and tumour control in both resectable and unresectable settings.

Gastrointestinal and Head and Neck Cancers

Research activity includes early-stage colorectal cancer and oropharyngeal cancer, with attention to organ preservation, local control, and functional outcomes.

  • Early-stage colorectal cancer
  • Oropharyngeal cancer

These trials involve radiotherapy, surgery, and quality of life considerations in both adult and adolescent populations.

Paediatric Oncology Surgery and Metastatic Disease

The sponsor also supports studies in pulmonary metastasis, renal tumours, and paratesticular rhabdomyosarcoma, with surgical research linked to lymph node dissection and tumour staging.

  • Pulmonary metastasis
  • Renal tumour
  • Paratesticular rhabdomyosarcoma

Additional interest is evident in image-guided surgery and oncological nodal assessment across complex paediatric cancers.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of drug combination therapy in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma using odronextamab, loncastuximab tesirine and rituximab

    Recruiting

    4 1 1 1
    Austria Belgium France The Netherlands Spain Sweden
  • Study of Regorafenib and Maintenance Chemotherapy for Newly Diagnosed Ewing Sarcoma Patients with Metastatic Disease

    Recruiting

    3 1 1 1
    Investigated diseases:
    Denmark France The Netherlands Norway Spain
  • Study of drug combinations including cisplatin, carboplatin, doxorubicin, fluorouracil, vincristine, etoposide, irinotecan, gemcitabine, oxaliplatin and sorafenib for children with hepatoblastoma or hepatocellular carcinoma

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Czechia France Germany Ireland +4
  • Study of drug combination therapy for patients with recurrent and primary refractory Ewing Sarcoma

    Recruiting

    4 1 1 1
    Austria Belgium Czechia Denmark Finland France +4
  • Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark Finland Germany +4
  • Comparison of ruxolitinib versus hydroxycarbamide or interferon alfa as first treatment for high-risk polycythemia vera patients

    Recruiting

    3 1 1 1
    France